View Older Stories View More Recent Stories

Mar 6, 2025 10:16AM Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $63 at Morgan Stanley
Mar 5, 2025 06:47AM H.C. Wainwright Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN)
Mar 5, 2025 05:21AM Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $63 at Jefferies
Mar 4, 2025 10:39AM TD Cowen on Biohaven Pharmaceutical Holding (BHVN): 'BHV-1300 Is Crushing Its Target'
Mar 4, 2025 10:26AM RBC on Biohaven Pharmaceutical Holding (BHVN): 'Stock Reaction Overdone On Bipolar Miss'
Mar 4, 2025 06:52AM Bernstein: 'Still like Biohaven Pharmaceutical Holding (BHVN) Stock but No Longer a Top Pick'; PT Lowered
Mar 3, 2025 04:25PM Biohaven Pharma (BHVN) Misses Q4 EPS by 11c
Mar 3, 2025 12:35PM Piper Sandler Reiterates Overweight Rating on Biohaven Pharmaceutical Holding (BHVN)
Mar 3, 2025 07:31AM Biohaven Pharma (BHVN) Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300
Feb 11, 2025 07:31AM Biohaven Pharma (BHVN) Announces FDA Acceptance and Priority Review of Troriluzole NDA
Feb 11, 2025 04:15AM Deutsche Bank Starts Biohaven Pharmaceutical Holding (BHVN) at Buy
Jan 29, 2025 09:12AM Cantor Fitzgerald provides update on Biotechnology stocks
Jan 13, 2025 12:50PM RBC Capital Explores Biotech Implications Following Cavazzoni's Departure from the FDA
Jan 8, 2025 06:00PM Bernstein's top two SMID biotech picks for 2025
Dec 17, 2024 06:51AM H.C. Wainwright Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN)
Dec 17, 2024 06:47AM Bernstein on Biohaven Pharmaceutical Holding (BHVN): 'BHVN Remains One of Our Top Picks'
Dec 16, 2024 07:30AM Biohaven Pharma (BHVN) Reports Positive Phase 1 Degrader Data
Dec 6, 2024 07:30AM Biohaven Pharma (BHVN) Presents New Data with BHV-7000 Once-Daily Extended-Release Formulation Demonstrating Excellent Safety Profile and Nonclinical Data Updates
Dec 4, 2024 08:59AM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $61 at RBC Capital
Dec 2, 2024 04:00PM Here are the key catalysts for 3 US biotech stocks into year end
Nov 30, 2024 04:00AM Is Trump 2.0 good or bad for healthcare stocks?
Nov 25, 2024 11:24AM Baird Reiterates Outperform Rating on Biohaven Pharmaceutical Holding (BHVN)
Nov 25, 2024 09:46AM Piper Sandler Reiterates Overweight Rating on Biohaven Pharmaceutical Holding (BHVN)
Nov 25, 2024 07:43AM Biohaven Pharma (BHVN) Falls 13% Following Update on Taldefgrobep Alfa Development Program for Spinal Muscular Atrophy and Obesity
Nov 25, 2024 07:32AM Biohaven Pharma (BHVN) Provides Update on Taldefgrobep Alfa Development Program
Nov 13, 2024 11:18AM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $75 at TD Cowen
Nov 13, 2024 06:44AM Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $66 at RBC Capital
Nov 12, 2024 04:09PM Biohaven Pharma (BHVN) Misses Q3 EPS by 4c
Oct 15, 2024 06:12AM BofA Securities Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN)
Oct 7, 2024 04:08PM Leerink Partners Reiterates Outperform Rating on Biohaven Pharmaceutical Holding (BHVN)
Oct 7, 2024 03:41PM BTIG Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN)
Oct 7, 2024 10:20AM Baird Reiterates Outperform Rating on Biohaven Pharmaceutical Holding (BHVN)
Oct 7, 2024 06:16AM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $63 at BofA Securities
Oct 3, 2024 06:01AM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $68 at JPMorgan
Oct 1, 2024 07:43AM TD Cowen Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN)
Oct 1, 2024 06:14AM Biohaven Pharma (BHVN) Prices 5.26M Share Offering at $47.50/sh
Sep 30, 2024 05:01PM After-hours movers: IGM Biosciences, Biohaven Pharma, Acadia Realty Trust
Sep 30, 2024 04:06PM Biohaven Pharma (BHVN) Announces Proposed $250M Share Offering
Sep 30, 2024 07:31AM Biohaven Pharma (BHVN) Initiates Pivotal Trial of BHV-2100 for Treatment of Migraine
Sep 24, 2024 09:45AM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $60 at Leerink Partners
Sep 24, 2024 06:47AM H.C. Wainwright Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN)
Sep 24, 2024 06:21AM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $62 at BofA Securities
Sep 24, 2024 06:14AM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $68 at RBC Capital
Sep 23, 2024 01:59PM TD Cowen Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN)
Sep 23, 2024 12:17PM BTIG Reiterates Buy Rating on Biohaven Pharmaceutical Holding (BHVN), PT $59
Sep 23, 2024 12:17PM Biohaven Pharmaceutical Holding (BHVN) PT Raised to $60 at Baird
Sep 23, 2024 11:01AM Piper Sandler Reiterates Overweight Rating on Biohaven Pharmaceutical Holding (BHVN)
Sep 23, 2024 08:19AM Biohaven Pharma (BHVN) Climbs 15% Following Positive Topline Results in Pivotal Study of Troriluzole in Spinocerebellar Ataxia
Sep 23, 2024 07:30AM Biohaven Pharma (BHVN) Reports Positive Topline Results in Pivotal Study of Troriluzole in Spinocerebellar Ataxia
Sep 16, 2024 06:26AM Jefferies Starts Biohaven Pharmaceutical Holding (BHVN) at Buy
View More Recent Stories View Older Stories